Mondaq USA: Food, Drugs, Healthcare, Life Sciences > Food and Drugs Law
Wolf, Greenfield & Sacks, P.C.
The USPTO refused registration of the mark HULA DELIGHTS for "gift baskets featuring processed nuts," finding a likelihood of confusion with the registered mark HULA PRINCESS
Klein Moynihan Turco LLP
To date, the United States Patent and Trademark Office ("PTO") has refused registration for cannabis and derivative products on the basis that such goods were unlawful for use under federal law.
Mintz
This week, the full House is poised to take its first action on drug pricing, voting on a pair of bills that would improve access to drug patents.
Ward and Smith, P.A.
In February, the North Carolina Department of Agriculture & Consumer Services (the "Department") disclosed its intent to issue CBD Advisory Letters to hemp and CBD industry participants
Wilson Elser Moskowitz Edelman & Dicker LLP
Advising companies on CBD (cannabidiol) risk management is made challenging by the rapid pace of developments and frequent confusion caused by often false or misleading online information.
Seyfarth Shaw LLP
The Illinois General Assembly has been working on a marijuana legalization bill this session.
BakerHostetler
Below is this week's "Capitol Hill Healthcare Update," which is posted on Mondays when Congress is in session.
Seyfarth Shaw LLP
Now it seems some jurisdictions are stepping in and granting certain employment protections to off-duty marijuana users.
Shelston IP
Patent practitioners should include functional features in a claim if there is insufficient experimental evidence provided.
Fish & Richardson PC
Decisions in the Amgen v. Sandoz case involving Sandoz's biosimilar versions of Amgen's Neupogen® and Neulasta® drugs have provided significant guidance to biosimilar litigants over the years.
Foley & Lardner
The Biologics Price Competition and Innovation Act (BPCIA) has been criticized for creating a complicated framework for resolving patent disputes, often referred to as the biosimilar "patent dance."
Duane Morris LLP
On May 2, 2019, the United States Patent and Trademark Office (USPTO) made available a new examination guide aimed at clarifying
McDermott Will & Emery
On April 23, 2019, the US Department of Justice (DOJ) announced it has entered into a deferred prosecution agreement with Rochester Drug Co-Operative, Inc. (RDC),
Akin Gump Strauss Hauer & Feld LLP
On May 1, 2019, a three-judge panel of the Court of Appeals for the Federal Circuit issued its long-awaited decision in Amarin Pharmaceuticals, Inc. v. ITC.
Hogan Lovells
Many food and beverage companies are assessing the use of hemp-derived ingredients in their products in light of the 2018 Farm Bill
BakerHostetler
Administration highlights supplement ingredients that might otherwise be missed
BakerHostetler
The acting commissioner covered opioids, the safety of imported foods and possible changes to the cosmetics regulatory regime during his address to attendees at the 2019 FDLI Annual Conference.
BakerHostetler
Below is the Federal Policy team's weekly preview, published when Congress is in session.
Wilson Elser Moskowitz Edelman & Dicker LLP
In March and April 2019, lawmakers in Connecticut unveiled a plan to legalize marijuana for recreational use and retail sales to adults over the age of 21 years.
Ropes & Gray LLP
On April 24, 2019, the Food and Drug Administration ("FDA") released a draft guidance, entitled "Initiation of Voluntary Recalls Under 21 CFR Part 7, Subpart C,"
Latest Video
Most Popular Recent Articles
Foley Hoag LLP
The symbol at right is one of the three candidate food labeling symbols indicating the presence of "bioengineered foods" being proposed ...
BakerHostetler
Partners Carl Hittinger and Jeffry Duffy authored an article published by The Legal Intelligencer on July 27, 2018.
Holland & Knight
The Centers for Medicare & Medicaid Services (CMS) on Nov. 1, 2018, published the Calendar Year (CY) 2019 Final Rule for the Medicare Physician Fee Schedule (PFS).
Reed Smith
This message is directed primarily to our overseas readers, and those who represent non-United States drug and medical device companies. Under FDA registration regulations,
Gibson, Dunn & Crutcher
Two years into the Trump Administration, the regulatory and enforcement landscape impacting health care providers continues to be extraordinarily dynamic and complex.
Wilson Elser Moskowitz Edelman & Dicker LLP
Both Pennsylvania and New Jersey have governors who have expressed an interest in legalizing cannabis for recreational
Dentons
The big news this week is Canopy Growth Corp.'s announcement that it plans to acquire Acreage Holdings, Inc., a leading US multistate cannabis operator,
Lewis Roca Rothgerber Christie LLP
Fair use protection does not apply in the circumstance of marijuana-infused products because the trademarks are used as a "designation of source"
Seyfarth Shaw LLP
The Illinois General Assembly has been working on a marijuana legalization bill this session.
Duff and Phelps
Mergers & Acquisitions (M&A) deal activity in the food and beverage industry remains strong, with 283 deals closing in the last 12 months (LTM) to March 31, 2019.
Article Search Using Filters
Related Topics
Mondaq Advice Center (MACs)
Popular Authors
Popular Contributors
Up-coming Events Search
Tools
Font Size:
Translation
Channels
Mondaq on Twitter
Partners
In association with